Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
|ClinicalTrials.gov Identifier: NCT02551744|
Recruitment Status : Completed
First Posted : September 16, 2015
Results First Posted : August 8, 2019
Last Update Posted : August 8, 2019
Kaohsiung Veterans General Hospital.
Information provided by (Responsible Party):
Ping-I (William) Hsu, M.D., Kaohsiung Veterans General Hospital.
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Prevention|
Drug: histamine-2 receptor antagonist group
Drug: proton pump inhibitor group
The trial was performed in a single country